"the treatment of our family and the behaviour of the western trust has been disgraceful, they should be ashamed of themselves...

erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.

"he didn't want to leave," nunley said. "he just wanted to stay with her.".

following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)..